CN104187727A - Seal oil soft capsule containing salvia miltiorrhiza extract - Google Patents
Seal oil soft capsule containing salvia miltiorrhiza extract Download PDFInfo
- Publication number
- CN104187727A CN104187727A CN201410451354.8A CN201410451354A CN104187727A CN 104187727 A CN104187727 A CN 104187727A CN 201410451354 A CN201410451354 A CN 201410451354A CN 104187727 A CN104187727 A CN 104187727A
- Authority
- CN
- China
- Prior art keywords
- seal oil
- soft capsule
- oil soft
- salvia miltiorrhiza
- seal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 14
- 241000304195 Salvia miltiorrhiza Species 0.000 title abstract 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 title abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 10
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 6
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000010445 lecithin Nutrition 0.000 claims abstract description 6
- 239000000787 lecithin Substances 0.000 claims abstract description 6
- 229940067606 lecithin Drugs 0.000 claims abstract description 6
- 229940031439 squalene Drugs 0.000 claims abstract description 6
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 241001072909 Salvia Species 0.000 claims description 11
- 235000017276 Salvia Nutrition 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 3
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims description 2
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021290 n-3 DPA Nutrition 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 9
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 235000019197 fats Nutrition 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 235000021294 Docosapentaenoic acid Nutrition 0.000 abstract description 3
- 208000007536 Thrombosis Diseases 0.000 abstract description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 3
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 2
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 2
- 206010002482 Angiosclerosis Diseases 0.000 abstract 1
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010011084 Coronary artery embolism Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000019240 optic nerve development Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a seal oil soft capsule containing a salvia miltiorrhiza extract. The seal oil soft capsule comprises the following main active ingredients: seal oil, the salvia miltiorrhiza extract and lecithin, wherein the seal oil contains EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid), DPA (docosapentaenoic acid) and squalene. The seal oil soft capsule also comprises the following main auxiliary materials: water, vitamin E, glycerol and edible animal gelatin. The seal oil soft capsule has the beneficial effects that the seal oil soft capsule not only can effectively reduce the contents of cholesterol and fat in the blood, reduce the blood viscosity, soften and dilate blood vessels and prevent the diseases such as arteriosclerosis, angiosclerosis, thrombus and the like but also has the functions of nourishing the brains, improving memory and preventing hypertension.
Description
(1) technical field
The present invention relates to a kind of soft capsule of fur seal, especially a kind of soft capsule of fur seal that contains Salvia root P.E, belongs to health food technology field.
(2) background technology
At present, along with improving constantly of living standard, people constantly increase the intake of higher fatty acid meat product, incident is the continuous rising of Blood Cholesterol and fat content, and the diseases such as the heart causing thus, cerebral artery vessel sclerosis, thrombus, coronary heart disease and hypertension affect and endangering the elderly's health day by day.In order to prevent and reduce the generation of this type of disease, people start more edible fur seal oils health foods, in order to reduce cholesterol and the fat content in blood.Because existing various fur seal oils health food ubiquity functional components on market are simple, effect becomes the irrational shortcoming of content ratio, the function singleness of product, DeGrain, be difficult to play desirable prevent disease and health-care effect.
(3) summary of the invention
The present invention is in order to make up the deficiencies in the prior art, a kind of soft capsule of fur seal that contains Salvia root P.E is provided, main active ingredient is: seal oil [contain EPA(eicosapentaenoic acid), DHA(DHA), DPA(clupanodonic acid), squalene], lecithin, Salvia root P.E, major auxiliary burden is water, vitamin E, glycerine and edible animal gelatin.
EPA in seal oil: be commonly called as " blood vessel street cleaner ", can reduce blood fat and cholesterol level, suppress platelet aggregation, there is the vascular sclerosis of preventing, cardiovascular and cerebrovascular embolism, reduce hypertensive effect.Can prevent coronary sclerosis and embolism, headstroke, cerebral hemorrhage, cerebrovascular disorder, high cholesterol, high fat of blood, hypertension, hand and foot numbness, the various cardiovascular and cerebrovascular diseases such as palpitaition.DHA: being commonly called as " docosapentaenoic acid ", is the necessary nutriment of brain tissue and optic nerve development and Function.Can be used for strengthening memory, promote infant's intellectual development and improve IQ, prevention and treatment senile dementia.DPA: can improve the immunity of human body, to diabetes, rheumatoid arthritis, psoriasis, asthma, ulcer colo-enteritis etc. all has therapeutic action.Squalene: natural, contributes to anti-cancer and anticancer, and can make it smooth and full of elasticity by skin care.
Salvia root P.E has cardiac nutrition, hemangiectasis, improves peripheral blood circulation, reduces the effect of blood sugar and blood fat, is widely used in prevention and the health-care effect of cardiovascular and cerebrovascular disease.Lecithin has nutrition brain prevention softening blood vessel and slows down the effect being losing one's memory.
Vitamin E can protect highly unsaturated fatty acid (EPA, DHA, DPA) not oxidized, extends shelf life of products.
The invention has the beneficial effects as follows, this soft capsule of fur seal not only can reduce cholesterol in blood and fat content, reduction blood viscosity effectively, soften and hemangiectasis, the generation of the diseases such as prevention of arterial vascular sclerosis, thrombus, but also nutritious brain, improve memory, the pathogenetic effect of preventing hypertension.
(4) specific embodiment
1, preparation content: raw material seal oil, Salvia root P.E oil, vitamin E is admixed together according to certain formula, stir, the EPA that the mass percent of capsule 's content functional component net content is 10～15%, 20～25% DHA, 10～15% DPA, 4～8% squalene, 5～6% lecithin, 2～3% Salvia root P.E and 1% vitamin E, all the other are other the non-functional component in seal oil.
2, make capsule body material: take edible gelatin, glycerine and pure water as utricule raw material, glycerine and pure water are proportionally injected in glue pot, and heating is stirred to 75 ℃ of left and right, then adds gelatin, continue to stir final vacuum deaeration in 20～30 minutes, make and obtain envelop materials.
3, the content preparing and capsule body are passed through to pelleting, moulding, wash ball, are dried, make finished product soft capsule of fur seal.
Claims (2)
1. the soft capsule of fur seal that contains Salvia root P.E, is characterized in that: the mass percent of capsule 's content raw material be seal oil [contain EPA(eicosapentaenoic acid), DHA(DHA), DPA(clupanodonic acid), squalene]: 90～92%, Salvia root P.E: 2～3%, lecithin 5～6%, vitamin E: 1%.
2. a kind of soft capsule of fur seal that contains Salvia root P.E according to claim 1, it is characterized in that: the mass percent of capsule 's content functional component is: EPA:10～15%, DHA:20～25%, DPA:10～15%, squalene 4～8%, Salvia root P.E: 2～3%, lecithin 5～6%, other the non-functional component in all the other vitamin Es that are 1% (antioxidant) and seal oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410451354.8A CN104187727A (en) | 2014-09-07 | 2014-09-07 | Seal oil soft capsule containing salvia miltiorrhiza extract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410451354.8A CN104187727A (en) | 2014-09-07 | 2014-09-07 | Seal oil soft capsule containing salvia miltiorrhiza extract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104187727A true CN104187727A (en) | 2014-12-10 |
Family
ID=52073242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410451354.8A Pending CN104187727A (en) | 2014-09-07 | 2014-09-07 | Seal oil soft capsule containing salvia miltiorrhiza extract |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104187727A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2764076C1 (en) * | 2021-06-03 | 2022-01-13 | Общество с ограниченной ответственностью "Академия-Т" | Biologically active food supplement |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518989A (en) * | 2003-01-21 | 2004-08-11 | 刘 威 | Soft capsule of fur seal and application in preparing health products for regulating blood fat |
| CN103989180A (en) * | 2014-05-07 | 2014-08-20 | 宁波市成大机械研究所 | Deep sea fish oil soft capsule containing salvia miltiorrhiza extract |
-
2014
- 2014-09-07 CN CN201410451354.8A patent/CN104187727A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518989A (en) * | 2003-01-21 | 2004-08-11 | 刘 威 | Soft capsule of fur seal and application in preparing health products for regulating blood fat |
| CN103989180A (en) * | 2014-05-07 | 2014-08-20 | 宁波市成大机械研究所 | Deep sea fish oil soft capsule containing salvia miltiorrhiza extract |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2764076C1 (en) * | 2021-06-03 | 2022-01-13 | Общество с ограниченной ответственностью "Академия-Т" | Biologically active food supplement |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103652867B (en) | A kind of health-care flax powder and production method thereof | |
| CN102919383A (en) | Blend oil containing peony seed oil and preparation method of blend oil | |
| CN102894107A (en) | Nutritional walnut oil and production process thereof | |
| CN103385493A (en) | Healthy food using Antarctic krill oil as main ingredient | |
| CN104082751A (en) | Deep sea fish oil soft capsule containing astaxanthin | |
| CN104171025A (en) | Selenium-rich edible oil suitable for women and children | |
| CN103082034A (en) | Health-care blend oil | |
| CN103989179A (en) | Deep sea fish oil soft capsule containing ginkgo leaf extract | |
| CN105768052A (en) | Health-care salad dressing and preparing method thereof | |
| CN102232430A (en) | Health-care oil | |
| CN108651635A (en) | Has effects that the nutrition-balanced health-care edible oil of brain boosting and supplementing | |
| CN103989181A (en) | Walnut oil-containing fish oil soft capsule | |
| CN104000208A (en) | Soft deep sea fish oil capsule containing squalene | |
| CN103989180B (en) | Deep-sea fish oil soft capsules containing Salvia root P.E | |
| CN103989176B (en) | Deep-sea fish oil soft capsules containing kudzu root extract | |
| CN104187727A (en) | Seal oil soft capsule containing salvia miltiorrhiza extract | |
| CN104187676A (en) | Seal oil soft capsule containing kudzuvine root extract | |
| CN103461542B (en) | Confinement oil capable of being taken directly | |
| CN102894095B (en) | Manufacture method of black bean milk with high anthocyanin content | |
| CN105707291A (en) | Camellia blend oil suitable for wet nurse | |
| CN104187726A (en) | Seal oil soft capsule containing dogbane extract | |
| CN104187728A (en) | Seal oil soft capsule containing walnut kernel extract | |
| CN104187674A (en) | Seal oil soft capsule containing ginkgo biloba extract | |
| CN104187675A (en) | Seal oil soft capsule containing ginkgo biloba oil | |
| CN104082741A (en) | Soft seal oil capsule containing astaxanthin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141210 |